Mitigating Prior Authorization Burdens: Insights from Reference Committee G

Key Takeaways

• Ninety-three percent of physicians report delays in patient care due to prior authorization.
• Eighty-two percent of patients abandon treatment because of prior authorization barriers.
• The American Medical Association (AMA) is developing a database to analyze prior authorization impacts.
• Legal action against insurers is being considered based on prior authorization data.
• Prior authorization processes contribute to physician burnout.

What is the focus of this document?

The document addresses the excessive burdens of prior authorization processes on healthcare providers and patients, outlining the AMA's policy responses and proposed actions.

Why does this matter for pharma teams?

Understanding the challenges posed by prior authorization is crucial for pharma teams to navigate regulatory environments and advocate for policies that facilitate patient access to medications.

Frequently Asked Questions

What is prior authorization?

Prior authorization is a process used by health insurers requiring physicians to receive approval from plans before certain prescribed medications, procedures, or treatments can be provided to patients.

What is the AMA's role in addressing prior authorization issues?

The AMA is actively generating a prior authorization database, strengthening public awareness campaigns, and considering legal action against insurance companies based on prior authorization data.

What are the consequences of prior authorization delays?

Delays in prior authorization can lead to patients abandoning treatment, serious adverse events, and increased physician burnout.